{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T08:29:16Z","timestamp":1792398556058,"version":"4.4.0"},"reference-count":47,"publisher":"Impact Journals, LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2019,12,31]]},"DOI":"10.18632\/aging.102598","type":"journal-article","created":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T18:33:40Z","timestamp":1577817220000},"page":"80-105","source":"Crossref","is-referenced-by-count":49,"title":["Ubenimex induces autophagy inhibition and EMT suppression to overcome cisplatin resistance in GC cells by perturbing the CD13\/EMP3\/PI3K\/AKT\/NF-\u03baB axis"],"prefix":"10.18632","volume":"12","author":[{"given":"Qie","family":"Guo","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan-Jing","family":"Jing","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Lin","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Min","family":"Xing","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Kai","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan-Bo","family":"Jing","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266003, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2019,12,31]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/apt.12814","article-title":"Review article: the epidemiology and prevention of gastric cancer.","volume":"4","author":"Fock","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.5009\/gnl14118","article-title":"Diagnosis and management of high risk group for gastric cancer.","volume":"9","author":"Kim","year":"2015","journal-title":"Gut Liver"},{"key":"3","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.3748\/wjg.v22.i8.2403","article-title":"Advanced gastric cancer: current treatment landscape and future perspectives.","volume":"2","author":"Wagner","year":"2016","journal-title":"World J Gastroenterol"},{"key":"4","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1590\/S0004-28032013000200042","article-title":"Perioperative chemotherapy in locally advanced gastric cancer.","volume":"5","author":"Almeida","year":"2013","journal-title":"Arq Gastroenterol"},{"key":"5","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1200\/JCO.2014.60.1799","article-title":"Update on metastatic gastric and esophageal cancers.","volume":"3","author":"Shah","year":"2015","journal-title":"J Clin Oncol"},{"key":"6","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.gene.2015.11.013","article-title":"MiR-181a suppresses autophagy and sensitizes gastric cancer cells to cisplatin.","volume":"57","author":"Lin","year":"2016","journal-title":"Gene"},{"key":"7","doi-asserted-by":"publisher","first-page":"16087","DOI":"10.1038\/cddiscovery.2016.87","article-title":"Aquaporin 3 facilitates chemoresistance in gastric cancer cells to cisplatinautophagy.","volume":"2","author":"Shen","year":"2016","journal-title":"Cell Death Discov"},{"key":"8","doi-asserted-by":"publisher","first-page":"4271","DOI":"10.7314\/APJCP.2014.15.10.4271","article-title":"An epigenetic mechanism underlying doxorubicin induced EMT in the human BGC-823 gastric cancer cell.","volume":"1","author":"Zhang","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"9","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0304-3835(00)00535-8","article-title":"Establishment and characterization of 5-fluorouracil-resistant gastric cancer cells.","volume":"15","author":"Yoo","year":"2000","journal-title":"Cancer Lett"},{"key":"10","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.3892\/mmr.2013.1400","article-title":"Overexpression of AKT decreases the chemosensitivity of gastric cancer cells to cisplatin in vitro and in vivo.","volume":"7","author":"Yu","year":"2013","journal-title":"Mol Med Rep"},{"key":"11","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.3892\/mmr.2016.5426","article-title":"Bufalin reverses intrinsic and acquired drug resistance to cisplatin through the AKT signaling pathway in gastric cancer cells.","volume":"1","author":"Liu","year":"2016","journal-title":"Mol Med Rep"},{"key":"12","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1006\/geno.1998.5238","article-title":"Chromosomal mapping of Tmp (Emp1), Xmp (Emp2), and Ymp (Emp3), genes encoding membrane proteins related to Pmp22.","volume":"4","author":"Benvenisty","year":"1998","journal-title":"Genomics"},{"key":"13","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1517\/14728220902988549","article-title":"EMP3 as a candidate tumor suppressor gene for solid tumors.","volume":"1","author":"Hiyama","year":"2009","journal-title":"Expert Opin Ther Targets"},{"key":"14","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1002\/ijc.21968","article-title":"Analysis of genes upregulated by the demethylating agent 5-aza-2\u2032-deoxycytidine in gastric cancer cell lines.","volume":"11","author":"Saisho","year":"2006","journal-title":"Int J Cancer"},{"key":"15","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.molmed.2008.06.003","article-title":"The moonlighting enzyme CD13: old and new functions to target.","volume":"1","author":"Mina-Osorio","year":"2008","journal-title":"Trends Mol Med"},{"key":"16","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.3892\/ijo.25.5.1223","article-title":"The ectopeptidases CD10, CD13, CD26, and CD143 are upregulated in gastric cancer.","volume":"2","author":"R\u00f6cken","year":"2004","journal-title":"Int J Oncol"},{"key":"17","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0753-3322(91)90129-H","article-title":"Effect of ubenimex on the immune system of patients with hematological malignancies.","volume":"4","author":"Ichihara","year":"1991","journal-title":"Biomed Pharmacother"},{"key":"18","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.1172\/JCI42550","article-title":"CD13 is a therapeutic target in human liver cancer stem cells.","volume":"12","author":"Mori","year":"2010","journal-title":"J Clin Invest"},{"key":"19","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1021\/jm970624o","article-title":"Novel potent nonpeptide aminopeptidase N inhibitors with a cyclic imide skeleton.","volume":"4","author":"Hashimoto","year":"1998","journal-title":"J Med Chem"},{"key":"20","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.juro.2013.12.001","article-title":"Potential significance of EMP3 in patients with upper urinary tract urothelial carcinoma: crosstalk with ErbB2-PI3K-Akt pathway.","volume":"19","author":"Chow","year":"2014","journal-title":"J Urol"},{"key":"21","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.4161\/auto.20353","article-title":"Immunohistochemical detection of cytoplasmic LC3 puncta in human cancer specimens.","volume":"8","author":"Kroemer","year":"2012","journal-title":"Autophagy"},{"key":"22","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/nrm2529","article-title":"Autophagic cell death: the story of a misnomer.","volume":"9","author":"Levine","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"23","doi-asserted-by":"publisher","first-page":"587","DOI":"10.4161\/cbt.24591","article-title":"Effect of doxorubicin, oxaliplatin, and methotrexate administration on the transcriptional activity of BCL-2 family gene members in stomach cancer cells.","volume":"1","author":"Scorilas","year":"2013","journal-title":"Cancer Biol Ther"},{"key":"24","doi-asserted-by":"publisher","first-page":"150845","DOI":"10.1155\/2014\/150845","article-title":"Apoptosis and molecular targeting therapy in cancer.","volume":"201","author":"Sakuragi","year":"2014","journal-title":"BioMed Res Int"},{"key":"25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ceb.2016.06.002","article-title":"Epithelial-mesenchymal transition (EMT) and metastasis: yes, no, maybe?","volume":"4","author":"Christofori","year":"2016","journal-title":"Curr Opin Cell Biol"},{"key":"26","doi-asserted-by":"publisher","first-page":"34859","DOI":"10.18632\/oncotarget.5414","article-title":"Targeting EMP3 suppresses proliferation and invasion of hepatocellular carcinoma cells through inactivation of PI3K\/Akt pathway.","volume":"6","author":"Chou","year":"2015","journal-title":"Oncotarget"},{"key":"27","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.biopha.2013.10.003","article-title":"Tamoxifen reduces P-gp-mediated multidrug resistance via inhibiting the PI3K\/Akt signaling pathway in ER-negative human gastric cancer cells.","volume":"6","author":"Dong","year":"2014","journal-title":"Biomed Pharmacother"},{"key":"28","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/febs.12577","article-title":"Up-regulation of survivin by AKT and hypoxia-inducible factor 1\u03b1 contributes to cisplatin resistance in gastric cancer.","volume":"28","author":"Sun","year":"2014","journal-title":"FEBS J"},{"key":"29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2012.01.005","article-title":"mTOR inhibitors in cancer therapy.","volume":"31","author":"Evers","year":"2012","journal-title":"Cancer Lett"},{"key":"30","doi-asserted-by":"publisher","first-page":"D986","DOI":"10.1093\/nar\/gkq995","article-title":"The Autophagy Database: an all-inclusive information resource on autophagy that provides nourishment for research.","volume":"3","author":"Sugawara","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"31","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1007\/s00018-010-0284-z","article-title":"Regulation of autophagy in mammals and its interplay with apoptosis.","volume":"6","author":"Piacentini","year":"2010","journal-title":"Cell Mol Life Sci"},{"key":"32","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1128\/MCB.01396-08","article-title":"p65\/RelA modulates BECN1 transcription and autophagy.","volume":"2","author":"Schneider","year":"2009","journal-title":"Mol Cell Biol"},{"key":"33","doi-asserted-by":"publisher","first-page":"13476","DOI":"10.18632\/oncotarget.3638","article-title":"Barill\u00e9-Nion.YM155 potently triggers cell death in breast cancer cells through an autophagy-NF-\u03baB network.","volume":"6","author":"Juin","year":"2015","journal-title":"Oncotarget"},{"key":"34","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/nrm1666","article-title":"Autophagy: dual roles in life and death?","volume":"6","author":"Baehrecke","year":"2005","journal-title":"Nat Rev Mol Cell Biol"},{"key":"35","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/cdd.2009.33","article-title":"Life and death partners: apoptosis, autophagy and the cross-talk between them.","volume":"1","author":"Kimchi","year":"2009","journal-title":"Cell Death Differ"},{"key":"36","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.tcb.2018.12.007","article-title":"Intersections between Regulated Cell Death and Autophagy.","volume":"2","author":"Fanto","year":"2019","journal-title":"Trends Cell Biol"},{"key":"37","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.bcp.2016.06.018","article-title":"3,3\u2032-Diindolylmethane induces anti-human gastric cancer cells by the miR-30e-ATG5 modulating autophagy.","volume":"11","author":"Lu","year":"2016","journal-title":"Biochem Pharmacol"},{"key":"38","doi-asserted-by":"publisher","first-page":"3907","DOI":"10.7314\/APJCP.2015.16.9.3907","article-title":"Antitumor activity of chloroquine in combination with Cisplatin in human gastric cancer xenografts.","volume":"1","author":"Wan","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"39","doi-asserted-by":"publisher","first-page":"5403","DOI":"10.3748\/wjg.v20.i18.5403","article-title":"Role of epithelial-mesenchymal transition in gastric cancer initiation and progression.","volume":"2","author":"Tong","year":"2014","journal-title":"World J Gastroenterol"},{"key":"40","first-page":"2141","article-title":"Epithelial-mesenchymal transition in gastric cancer.","volume":"7","author":"Xu","year":"2015","journal-title":"Am J Transl Res"},{"key":"41","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1038\/ncb1998","article-title":"The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs.","volume":"1","author":"Sansom","year":"2009","journal-title":"Nat Cell Biol"},{"key":"42","doi-asserted-by":"publisher","first-page":"7455","DOI":"10.1038\/sj.onc.1209085","article-title":"Perturbations of the AKT signaling pathway in human cancer.","volume":"2","author":"Testa","year":"2005","journal-title":"Oncogene"},{"key":"43","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3892\/ol.2014.2687","article-title":"Insulin-like growth factor-I induces epithelial to mesenchymal transition via GSK-3\u03b2 and ZEB2 in the BGC-823 gastric cancer cell line.","volume":"9","author":"Qu","year":"2015","journal-title":"Oncol Lett"},{"key":"44","doi-asserted-by":"publisher","first-page":"8323","DOI":"10.18632\/oncotarget.3200","article-title":"Zipper-interacting protein kinase promotes epithelial-mesenchymal transition, invasion and metastasis through AKT and NF-kB signaling and is associated with metastasis and poor prognosis in gastric cancer patients.","volume":"6","author":"Ma","year":"2015","journal-title":"Oncotarget"},{"key":"45","doi-asserted-by":"publisher","first-page":"72652","DOI":"10.18632\/oncotarget.20194","article-title":"Ubenimex suppresses Pim-3 kinase expression by targeting CD13 to reverse MDR in HCC cells.","volume":"8","author":"Jing","year":"2017","journal-title":"Oncotarget"},{"key":"46","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1158\/1535-7163.MCT-13-0722","article-title":"Immunotherapy for hepatoma using a dual-function vector with both immunostimulatory and pim-3-silencing effects.","volume":"1","author":"Zhang","year":"2014","journal-title":"Mol Cancer Ther"},{"key":"47","doi-asserted-by":"publisher","first-page":"3954","DOI":"10.1091\/mbc.e14-01-0004","article-title":"Lanthionine synthetase C-like protein 2 (LanCL2) is a novel regulator of Akt.","volume":"2","author":"Chen","year":"2014","journal-title":"Mol Biol Cell"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.102598","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T19:45:21Z","timestamp":1599075921000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.102598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,31]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1,15]]}},"alternative-id":["102598","31895687"],"URL":"https:\/\/doi.org\/10.18632\/aging.102598","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,31]]}}}